A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection
Clinical trial NCT00561015 · COMPLETED
Trial details
- NCT number
- NCT00561015
- Sponsor
- Tibotec BVBA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-06-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.